INJ. DETIZENE 200 MG

INJ. DETIZENE 200 MG
Product Description

USE IN -- IN THE TREATMENT OF METASTATIC MALIGNANT MELANOMA
- IN HODGKIN'S DESEASE AS A SECONDARY -LINE THERAPY WHEN USED IN COMBINATION WITH OTHER EFFECTIVE AGENTS.

Read more Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile

More Products from RMPL Pharma LLP (99)

  • INJ. 5 - FLU 500 MG

    Product INJ. 5 - FLU 500 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
  • INJ. 5 - FLU 250 MG

    Product INJ. 5 - FLU 250 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
  • TAB. ARIMIZOLE 1 MG

    Product TAB. ARIMIZOLE 1 MG

     - ANASTRAZOLE  IS USE FOR ADJUTANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER.- FOR THE FIRST LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER.
    - FOR THE TRE...
  • INJ. ELOPLAT 100 MG

    Product INJ. ELOPLAT 100 MG

    - ADJUVANT TREATMENT OF STAGE III COLON CANCER  IN PATIENTS WHO HAVE UNDERGONE COMPLETE RESECTION OF THE PRIMARY TUMOUR.- TREATMENT OF - ADVANCED COLORECTAL CANCER.
  • INJ. ELOPLAT 50 MG

    Product INJ. ELOPLAT 50 MG

    - ADJUVANT TREATMENT OF STAGE III COLON CANCER  IN PATIENTS WHO HAVE UNDERGONE COMPLETE RESECTION OF THE PRIMARY TUMOUR.- TREATMENT OF ADVANCED COLORECTAL CANCER.
  • INJ. DRONIZOL 4 MG

    Product INJ. DRONIZOL 4 MG

    USE IN -- HYPERCALCEMIA OF MALIGNANCY
    - BONE METASTASES OF SOLID TUMOURS.
  • INJ. DE- SOTAX 120 MG

    Product INJ. DE- SOTAX 120 MG

    USE IN -- DOCETAXEL IS A CHEMOTHERAPY DRUG. IT IS USED TO TREAT MANY TYPES OF CANCER INCLUDING BREAST , PROSTATE , STOMACH , HEAD AND NECK, AND NON -SMALL CELL LUNG CANCER .
  • INJ. DE-SOTAX 80 MG

    Product INJ. DE-SOTAX 80 MG

    USE IN -- DOCETAXEL IS A CHEMOTHERAPY DRUG. IT IS USED TO TREAT MANY TYPES OF CANCER INCLUDING BREAST , PROSTATE , STOMACH , HEAD AND NECK, AND NON -SMALL CELL LUNG CANCER .
  • INJ. DE-SOTAX 20 MG

    Product INJ. DE-SOTAX 20 MG

    USE IN -- DOCETAXEL IS A CHEMOTHERAPY DRUG. IT IS USED TO TREAT MANY TYPES OF CANCER INCLUDING BREAST , PROSTATE , STOMACH , HEAD AND NECK, AND NON -SMALL CELL LUNG CANCER .
  • INJ. CANTECAN 100 MG

    Product INJ. CANTECAN 100 MG

    USE IN -- CHEMOTHERAPY DRUG USED TO TREAT COLO CANCER . IT MAY ALSO USED TO TREAT CANCERS 
    - COLORECTAL CANCER
    - SYNONYMS COLON CANCER , RECTAL CANCER , BOWEL CANCER.
  • INJ. CANTECAN 40 MG

    Product INJ. CANTECAN 40 MG

    USE IN -- CHEMOTHERAPY DRUG USED TO TREAT COLO CANCER . IT MAY ALSO USED TO TREAT CANCERS 
    - COLORECTAL CANCER
    - SYNONYMS COLON CANCER , RECTAL CANCER , BOWEL CANCER.
  • INJ. CARBOPIN 450 MG

    Product INJ. CARBOPIN 450 MG

    USE IN -- INTITIAL TRATMENT OF ADVANCED OVARIAN CARCINOMA
    - SECONDARY TRATMENT OF ADVANCED OVARIAN CARCINOMA
show all 99 other products

RMPL Pharma LLP resources (1)

  • RMPL PHARMA LLP.

    Brochure RMPL PHARMA LLP.

    The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.